Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea

• Published in: Frontiers in aging neuroscience Vol. 14; p. 1037816
• Main Authors: Cumbo, Eduardo, Adair, Michael, Åstrom, Daniel Oudin, Christensen, Michael Cronquist
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 09.01.2023
• Subjects: Aging Neuroscience; Alzheimer’s disease; antidepressant; cognitive symptoms; depressive symptoms; major depressive disorder; vortioxetine; Alzheimer’s disease; major depressive disorder; vortioxetine; antidepressant; cognitive symptoms; cognitive performance; depressive symptoms

Vortioxetine has demonstrated procognitive effects in patients with major depressive disorder (MDD). We assessed the effectiveness and safety of vortioxetine in a cohort of patients with MDD and comorbid Alzheimer's disease participating in a large post-marketing surveillance study in South Kor...